EGF and toxic epidermal necrolysis: Recombinant human epidermal growth factor gel was employed to improve skin damage repair for partial patients (n=14, 22.2%), with TEN patients (n=5, 50.0%) accounting for the highest (P=0.048, Figure 4A).